Results 191 to 200 of about 4,224,729 (260)
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Counting Spinal Phylogenetic Networks. [PDF]
Francis A, Hendriksen M.
europepmc +1 more source
Chemical and Enantioselective Analysis of the Leaf Essential Oil from <i>Varronia crenata</i> Ruiz & Pav. Growing in Ecuador. [PDF]
Cazares K +4 more
europepmc +1 more source
Changing Gender Relations in Canada: The Rise of Gender-Neutral Forenames. [PDF]
Guppy N, Kolpashnikova K.
europepmc +1 more source
Notch2, a Key Player in Chronic Lymphocytic Leukemia: Mechanism, Microenvironment Interactions, and Therapeutic Implications. [PDF]
Miserendino R +4 more
europepmc +1 more source
Correction: A bibliometric analysis and systematic review of drug repurposing against drug-resistant ESKAPE pathogens: a particular focus on <i>Pseudomonas aeruginosa</i>. [PDF]
Frontiers Production Office.
europepmc +1 more source

